TABLE 2.

Cross tabulation of baseline and follow-up positive PYtest ([¹⁴C]urea breath test) results following 14-day oral administration of garenoxacin

Study medication and dose (mg)	No. of patients at day −2	No. (%) of test-positive subjects who were:
		Positive at follow-up		Negative at follow-up
		Day 17	Day 45	Day 17	Day 45
Placebo	7	7 (100)	6 (100)a	0 (0)	0 (0)
Garenoxacin
100	2	2 (100)	2 (100)	0 (0)	0 (0)
200	3	3 (100)	3 (100)	0 (0)	0 (0)
400	2	1 (50)	2 (100)	1 (50)	0 (0)
800	4	3 (75)	3 (75)	1 (25)	1 (25)
1,200	2	1 (50)	1 (50)	1 (50)	1 (50)

^aOne subject was missing but was considered positive for the percent calculation.